Prof. Dr. med. Andreas Hochhaus
internal medicine, hematology, and oncology
internal medicine, hematology, and oncology
Overview
Country, City
Germany, Jena
Health facility
University Hospital Jena
Medical unit
Department of hematology, oncology, and palliative medicine
3.7 on Google
The data collected based on
3
patient reviews on Google
About the doctor
Skills & Expertise
leukemia
myeloid leukemia
imatinib
nilotinib
dasatinib
cancer
myelogenous leukemia
ponatinib
mutation
stem cell transplantation
interferon
bosutinib
rectal cancer
capecitabine
lymphoblastic leukemia
bcrabl mutations
blast crisis
allogeneic stem cell
neoplasms
hematology
asciminib
malignancies
tumor
oncology
hematopoietic stem cell
chemotherapy
imatinibresistant chronic myeloid
bone marrow
colorectal cancer
systemic mastocytosis
chemoradiotherapy
myeloproliferative neoplasms
multiple myeloma
gastric cancer
internal medicine
hemophagocytic lymphohistiocytosis
eosinophilic leukemia
hypereosinophilic syndrome
myeloid blast
myeloid blast crisis
metastatic colorectal cancer
polycythemia
promyelocytic leukemia
hematological malignancies
epithelial tumor
thrombocythemia
cytogenetic aberrations
lymphoid blast
gastrointestinal cancer
colon
Resume
CV (Curriculum Vitae)
Education
- 1979-1985 Studied human medicine at the University of Leipzig and the Medical Academy in Erfurt
- Obtaining a license for medical practice
- Defense of the dissertation
- 1989 Obtaining specialization in internal medicine
- 1994 Received additional qualifications in the field of hematology and oncology
- 1997 Habilitation and a teaching license in internal medicine at the Mannheim medical faculty
- from the University of Heidelberg
Experience
- 1985-1989 Assistant Doctor at the Department of internal medicine of the Erfurt Medical Academy
- 1990-1997 III Mannheim medical clinic at the University of Heidelberg
- 1997-2009 Senior Physician of the III Mannheim medical clinic at the University of Heidelberg
- 2007 W3 Professorship for leukemia research at the Mannheim medical faculty of the University of Heidelberg
- 2009 W3 Professorship for internal medicine, hematology, and internal oncology at the Friedrich Schiller University Jena
- 2009 Director of the Department of hematology, oncology, and palliative medicine at the University Hospital Jena
- 2010-2020 Vice Dean for research at the faculty of medicine of the Friedrich Schiller University Jena
Awards & Memberships
- 1990 Member of the German Society for Hematology and Oncology
- 1999 Co-Applicant and Member of the board at the Competence Network "Acute and chronic leukemia"
- 2001 Member of the German Cancer Society
- 2002 Patent holder: "Mutated abl kinase domains"
- 2002 Patent holder: "Organic compounds"
- 2002 Member of the working group for internal oncology
- 2003 Co-Applicant and Member of the steering board at the European LeukemiaNet
- 2003-2012 Advisory Board Member of the German Society for Hematology and Oncology
- 2004 Patent holder: "Eleven BCR-ABL tyrosine kinase mutations during imatinib therapy"
- 2006 Patent holder: "Organic compounds"
- 2007-2013 Board Member of the working group for internal oncology
- 2008 Patent holder: "Methods Of Identifying And Treating Individuals Exhibiting Mutant Bcr/Abl Kinase Polypeptides"
- 2008 Patent holder: "Organic compounds"
- 2008 Patent holder: "Mutated Abl Kinase Domains"
- 2009 Member of the Thuringian Cancer Society
- 2009 Patent holder: “Mutated ABL kinase domains”
- 2010 Spokesman for the University Tumor Center at the Jena University Hospital
- 2010 Patent holder: "Organic compounds"
- 2010-2022 Member of the council of the faculty of medicine at the Jena University Hospital
- 2011 Chairman of the Thuringian Cancer Society
- 2012 Board Member of the German Cancer Society
- 2014 Editor-in-Chief of the LEUKEMIA
- 2014 Member of the Academy of Non-Profit Sciences in Erfurt
- 2016 Congress President of the German Society for Hematology and Oncology
- 2018 Member of the Saxon Academy of Sciences in Leipzig
- 2019-2023 Member of the Advisory Board of German Cancer Aid
- 2020 Congress President of the German Cancer Society
Languages
English
German
Publications
Nuclear war and physicians' social responsibility.
12 September, 2023
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European leukemia net risk classification.
7 September, 2023
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial.
September, 2023
Location
Am Klinikum, 1, 07747 Jena, Germany
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. med. Andreas Hochhaus?
The primary specialization of the doctor is internal medicine, hematology, and oncology.
What is the experience of the specialist?
Prof. Dr. med. Andreas Hochhaus has been practicing for more than 39 years.
Prof. Dr. med. Andreas Hochhaus
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. med. Andreas Hochhaus